Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy

This study presents the early framework of selective cell tagging (SeCT) therapy, which is the concept of preferentially labeling specific cells in vivo with chemical moieties that can elicit a therapeutic response. Using glycosylated artificial metalloenzyme (GArM)–based protein labeling, this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Vong, Kenward, Tahara, Tsuyoshi, Urano, Sayaka, Nasibullin, Igor, Tsubokura, Kazuki, Nakao, Yoichi, Kurbangalieva, Almira, Onoe, Hirotaka, Watanabe, Yasuyoshi, Tanaka, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064634/
https://www.ncbi.nlm.nih.gov/pubmed/33893089
http://dx.doi.org/10.1126/sciadv.abg4038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064634/
https://www.ncbi.nlm.nih.gov/pubmed/33893089
http://dx.doi.org/10.1126/sciadv.abg4038

Ejemplares similares